Completed OBSERVATIONAL NCT04871841

Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan

Sponsor: Karaganda Medical University

Conditions Covid19 Vaccine Adverse Reaction

Interventions Sputnik V

Updated 6 times since 2021 Last updated: Apr 11, 2024 Started: Apr 5, 2021 Primary completion: Sep 5, 2021 Completion: Jun 20, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Covid19 and Vaccine Adverse Reaction and is currently completed. Karaganda Medical University leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
May 2024 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Sep 2023 — May 2024 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Sep 2021 — Sep 2023 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting

▶ Show 1 earlier version

Jun 2021 — Sep 2021 [monthly]

Recruiting

First recorded

Apr 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Karaganda Medical University
McMaster University

Data source: Karaganda Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karaganda, Kazakhstan